Under the terms of the engagement, the Company provides strategic advisory services to Aquiva Medical to reinforce Aquiva’s growth and expansion initiatives.
Key Points:
- Under the terms of the engagement, the Company provides strategic advisory services to Aquiva Medical to reinforce Aquiva’s growth and expansion initiatives.
- Leveraging the Company’s extensive expertise and network within the healthcare and biotech industries, Aquiva Medical hopes to hasten its U.S. market penetration and enhance its product development efforts.
- In a recent milestone achievement, the Company advised Aquiva Medical in connection with Aquiva’s successfully consummated merger transaction with BHPA, Inc., marking a significant step forward for Aquiva.
- "We are thrilled about our engagement with Aquiva Medical and the early successes that we have achieved," said Edward Lee, CEO of Hestia Insight.
Retrieved on:
Thursday, December 21, 2023
Key features of the Company’s marketing plan include comprehensive integration of professional consultancy, top-tier talent acquisition, and cutting-edge AI solutions to optimize brand development and attract customers and partners.
Key Points:
- Key features of the Company’s marketing plan include comprehensive integration of professional consultancy, top-tier talent acquisition, and cutting-edge AI solutions to optimize brand development and attract customers and partners.
- The Company remains committed to providing affordability to its clients, with the goal of ensuring that emerging growth companies have access to world-class resources without undue financial strain.
- "Edward Lee, CEO of Hestia Insight, stated, “We are thrilled to pave the way for a new era of opportunities for emerging growth companies.
- Our new Marketing Plan underscores our commitment to driving innovation, fostering collaboration, and facilitating success in the rapidly evolving international business landscape."
“Our AI-powered website platform is www.Outreach360.us ,” said Edward Lee, CEO of Hestia Insight.
Key Points:
- “Our AI-powered website platform is www.Outreach360.us ,” said Edward Lee, CEO of Hestia Insight.
- “We are keenly aware of the challenges and difficulties that smaller companies often face in obtaining needed funding.
- “Through our new partnership with Escher Capital, we will offer more than 50 years of experience in angel investments, investment management, venture capital, investment banking and entrepreneurship combined with the power of AI.
- We are confident that through www.Outreach360.us , we can elevate businesses to augment their success rates within their budgetary constraints,” Mr. Lee concluded.
RecentCare Biomedical, established in 2013 in Taiwan, are leading experts at providing successful solutions for wound care.
Key Points:
- RecentCare Biomedical, established in 2013 in Taiwan, are leading experts at providing successful solutions for wound care.
- Its core technology has acquired multiple patent certifications and the company uses its hydrogel techniques in various fields, including medical, and skin care and drug delivery.
- Edward Lee, CEO of Hestia Insight, stated, “RecentCare Biomedical addresses a multi-billion-dollar world market, in which it can bring outstanding products to cure and comfort people worldwide.
- We are thrilled to have the opportunity to combine this exceptional company with the Hestia Insight family so that we may grow together to achieve a strong and prosperous organization.”
Hestia Insight has been active in searching for attractive potential acquisition targets in the healthcare sector with the goal of strengthening the Company’s business model and adding to its revenue, intellectual property, and global presence.
Key Points:
- Hestia Insight has been active in searching for attractive potential acquisition targets in the healthcare sector with the goal of strengthening the Company’s business model and adding to its revenue, intellectual property, and global presence.
- Prisma Biotech, established in 1995, is a leading distributor in the Asian-Pacific region providing high quality products and services in the clinical genomic, in-vitro diagnostics and life sciences sectors.
- The medical device and equipment brands that Prisma Biotech distributes include Illumina, Biodot, Sage Science, Vitrolife and other healthcare products.
- Prisma Biotech’s annual revenue in 2022 exceeded $7 Million USD, and it projects 2023 annual revenue of approximately $10 Million USD.
Retrieved on:
Thursday, January 5, 2023
West Virginia University,
OTCQB,
Hoffmann-La Roche,
Merck & Co.,
Drug development,
Merck,
Barakat Pharmaceutical Group,
Chaung-U,
Growth,
Massachusetts Institute of Technology,
National Taiwan University,
Bristol Myers Squibb,
Virginia University,
Marketing,
Pharmaceutical industry NEW YORK, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hestia Insight Inc. (OTCQB: HSTA) (“Hestia Insight” and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, as well as providing sales and marketing guidance and capital markets advisory services to its clients, today announced its appointment of an additional advisory board member to assist in the growth of the Company.
Key Points:
- NEW YORK, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hestia Insight Inc. (OTCQB: HSTA) (“Hestia Insight” and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, as well as providing sales and marketing guidance and capital markets advisory services to its clients, today announced its appointment of an additional advisory board member to assist in the growth of the Company.
- (Ted) Chaung, a seasoned independent healthcare consultant with broad experience in healthcare industry startups, new drug development, venture capital, and business development, in both the Taiwan and U.S. healthcare sectors, has joined the Company’s advisory board.
- “We are excited to welcome the addition of Dr. Ted Chaung to our Advisory Board,” stated Hestia Insight’s CEO and Chairman, Edward Lee.
- We look forward to utilizing Dr. Chaung’s impressive background and skill set to assist with the growth of Hesta Insight.”
Retrieved on:
Thursday, September 29, 2022
Securities Exchange Act of 1934,
Coffee,
OTCQB,
Company,
Acquisition,
Special-purpose acquisition company,
Growth,
USB,
Investment,
Private Securities Litigation Reform Act,
Partnership,
Industry,
Forward-looking statement,
Apple,
HSTA,
Terminology,
Annual report,
Android,
Restaurant,
GLOBE,
SEC,
Mission statement,
Mobile phone Hestia Vending, which recently announced its vending pilot program featuring HealthyYOU E-vending machines which dispense healthy food, beverage and wellness products, will introduce ChargerGoGo smart phone charging station and power bank kiosks in densely populated locations and venues for smart phone charging convenience.
Key Points:
- Hestia Vending, which recently announced its vending pilot program featuring HealthyYOU E-vending machines which dispense healthy food, beverage and wellness products, will introduce ChargerGoGo smart phone charging station and power bank kiosks in densely populated locations and venues for smart phone charging convenience.
- ChargerGoGo smart phone charging station and power banks allow users to obtain a portable battery from any ChargerGoGo kiosk, charge their smart phones, and avoid missing an important event or meeting.
- Smartphones are essential to daily life, said Edward Lee, Hestia Insight Chairman and CEO.
- Hestia Insight Inc. (Hestia Insight and the Company) is focused primarily on the healthcare and biotech sectors through the Companys two wholly owned operating subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA HEALTH INC., d/b/a Hestia Vending (Hestia Vending).
Retrieved on:
Thursday, September 29, 2022
Securities Exchange Act of 1934,
Inc.,
Coffee,
OTCQB,
Company,
Special-purpose acquisition company,
Growth,
Investment,
USB,
Acquisition,
Private Securities Litigation Reform Act,
Partnership,
Industry,
Forward-looking statement,
Apple,
CEO,
Terminology,
Annual report,
Android,
Restaurant,
GLOBE,
SEC,
Mission statement,
Mobile phone,
Security (finance) Hestia Health, which recently announced its vending pilot program featuring HealthyYOU E-vending machines which dispense healthy food, beverage, and wellness products, will introduce ChargerGoGo smart phone charging station and power bank kiosks in densely populated locations and venues for smart phone charging convenience.
Key Points:
- Hestia Health, which recently announced its vending pilot program featuring HealthyYOU E-vending machines which dispense healthy food, beverage, and wellness products, will introduce ChargerGoGo smart phone charging station and power bank kiosks in densely populated locations and venues for smart phone charging convenience.
- ChargerGoGo smart phone charging station and power banks allow users to obtain a portable battery from any ChargerGoGo kiosk, charge their smart phones, and avoid missing an important event or meeting.
- Smartphones are essential to daily life, said Edward Lee, Hestia Insight Chairman and CEO.
- Hestia Insight Inc. (Hestia Insight and the Company) is focused primarily on the healthcare and biotech sectors through the Companys two wholly owned operating subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA Health Inc. (HSTA Health).
Retrieved on:
Wednesday, September 21, 2022
Securities Exchange Act of 1934,
Infection,
Incidence,
Prevalence,
OTCQB,
Company,
The Advisory Board Company,
Wound healing,
Population,
Obesity,
Investment,
Private Securities Litigation Reform Act,
Growth,
Industry,
Diabetes,
Forward-looking statement,
Physician,
Terminology,
Annual report,
Acquisition,
GLOBE,
Marketing,
SEC,
Mission statement,
Pharmaceutical industry In the advanced wound care sector, RecentCare is developing a transdermal drug delivery system.
Key Points:
- In the advanced wound care sector, RecentCare is developing a transdermal drug delivery system.
- RecentCare is an impressive advanced wound care company dedicated to developing high-performance hydrogel dressings to improve wound healing.
- Their wound dressings are characterized by a high liquid-absorption rate, and are ultra-thin and transparent, said Edward Lee, Hestia Insights CEO and Chairman.
- Hestia Insight Inc. (Hestia Insight and the Company) is focused primarily on the healthcare and biotech sectors through the Companys two wholly owned operating subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA Health Inc. (HSTA Health).
Sale,
Acquisition,
Stanford University,
GLOBE,
Blockchain,
Business,
Industry,
Boston University,
Forward-looking statement,
SEC,
Private Securities Litigation Reform Act,
Securities Exchange Act of 1934,
Marketing,
Machine learning,
NLP,
Automation,
The Advisory Board Company,
Mission statement,
Company,
OTCQB,
Chartered Alternative Investment Analyst,
Health,
Investment,
Terminology,
Annual report,
Growth,
Pharmaceutical industry,
Engineering,
Science We are excited to welcome the addition of Mr. Edward Boyle to our Advisory Board, stated Hestia Insights CEO and Chairman, Edward Lee.
Key Points:
- We are excited to welcome the addition of Mr. Edward Boyle to our Advisory Board, stated Hestia Insights CEO and Chairman, Edward Lee.
- Hestia Insight Inc. (Hestia Insight and the Company) is focused primarily on the healthcare and biotech sectors through the Companys two wholly owned operating subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA Health Inc. (HSTA Health).
- The Company is positioned to make strategic acquisitions of emerging growth companies with unique sciences and technologies.
- The Company entered the healthcare sector to explore emerging healthcare technologies, especially growth companies that own and develop unique sciences and technologies.
